Corrigendum: Adverse drug events (ADEs) risk signal mining related to eculizumab based on the FARES database

Corrigendum: Adverse drug events (ADEs) risk signal mining related to eculizumab based on the FARES database

Saved in:

Bibliographic Details
Main Authors:	Xi-Feng Wang, Lu-Ri Bao, Ta-La Hu, Rui-Feng Xu, Wu-Niri Gao, Jing-Yuan Wang, Jian-Rong Zhao, Zhen-Li Fu, Shu-Fang Wang, Yan Meng
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-02-01
Series:	Frontiers in Pharmacology
Subjects:	eculizumab FAERS adverse drug events adverse drug reaction monitoring ADRM
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2025.1558930/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Adverse drug events (ADEs) risk signal mining related to eculizumab based on the FARES database
by: Xi-Feng Wang, et al.
Published: (2025-01-01)

Real-world pharmacovigilance study of drug-induced autoimmune hepatitis from the FAERS database
by: Bu-kun Zhu, et al.
Published: (2025-02-01)

Disproportionality analysis of upadacitinib-related adverse events in inflammatory bowel disease using the FDA adverse event reporting system
by: Shiyi Wang, et al.
Published: (2025-02-01)

Safety profiles of sevoflurane in pediatric patients: a real-world pharmacovigilance assessment based on the FAERS database
by: Chuang Yang, et al.
Published: (2025-02-01)

Analysis of ADR reports of cetuximab based on the FDA adverse event reporting system database
by: Shuai Zhao, et al.
Published: (2025-02-01)

Challenges in setting up the antiretroviral paediatric registry in South Africa: Lessons learned from Free State Province clinics
by: B R Omotoso, et al.
Published: (2024-07-01)

Adverse events in the nervous system associated with blinatumomab: a real-world study
by: Wen Gao, et al.
Published: (2025-02-01)

A hyper-acute immune hemolytic anemia induced by contrast medium was successfully treated with eculizumab: a case report
by: Sabine Hermann, et al.
Published: (2025-02-01)

Comparative Analysis of Adverse Drug Reactions Associated with Fluoroquinolones and Other Antibiotics: A Retrospective Pharmacovigilance Study
by: Alshareef H, et al.
Published: (2025-02-01)

Characteristics and contributing factors of adverse drug reactions: an analytical study of patients with tuberculosis receiving treatment under the National TB Program of India [version 2; peer review: 1 approved, 2 approved with reservations, 1 not approved]
by: Jay Patel, et al.
Published: (2024-07-01)

Investigating the Safety of Fampridine in Patients with Different Stages of Multiple Sclerosis
by: Saeed Vaheb, et al.
Published: (2025-01-01)

Évaluation de la prescription et de l’utilisation des benzodiazépines dans la ville de Sidi Bel-Abbès
by: Derouicha Matmour, et al.
Published: (2022-12-01)

High risk for life-threatening adverse events of fluoroquinolones in young adults: a large German population-based cohort study
by: Julia Wicherski, et al.
Published: (2025-02-01)

Black tongue caused by linezolid in children: One case report and literature review
by: Chunyu Zhang, et al.
Published: (2025-01-01)

A decade-long overview of adverse events in a tertiary surgical service in South Africa
by: H Wain, et al.
Published: (2024-10-01)

Safety profiles of IDH inhibitors: a pharmacovigilance analysis of the FDA Adverse Event Reporting System (FAERS) database
by: Ximu Sun, et al.
Published: (2025-02-01)

Association between CYP2C19 polymorphism and proton pump inhibitors adverse drug reactions: a narrative review
by: Asmaa Ibrahim, et al.
Published: (2025-02-01)

Assessing hemorrhagic risks in combination therapy: implications of angiogenesis inhibitors and immune checkpoint inhibitors
by: Yuhui Yang, et al.
Published: (2025-02-01)

Trends and factors associated with adverse pregnancy outcomes in Zimbabwe, 2005 - 2015
by: T Chibura, et al.
Published: (2024-06-01)

Comparisons of adverse events associated with immune checkpoint inhibitors in the treatment of non-small cell lung cancer: a real-world disproportionality analysis based on the FDA adverse event reporting system
by: Ruichen Gao, et al.
Published: (2025-02-01)

Prevalence, risk factors, and adverse perinatal outcomes in Chinese women with preeclampsia: a large retrospective cohort study
by: Lin Chai, et al.
Published: (2025-02-01)

Evaluation of the relationship between adversity quotient, professional identity, and perceived humanistic care of head nurses in Master’s Degrees in nursings
by: Cai Haina, et al.
Published: (2025-01-01)

Do past and present adverse experiences impact the mental health of children? A study among children in the Juvenile Justice System in India
by: Shiva Prakash Srinivasan, et al.
Published: (2023-08-01)

Adverse childhood experiences screening in pediatric primary care and changes in the rate of visits to social work and behavioral health
by: Sonya Negriff, et al.
Published: (2025-02-01)

Post-marketing safety surveillance for the recombinant zoster vaccine (Shingrix), vaccine adverse event reporting system, United States, October 2017–April 2024
by: Yamin Shu, et al.
Published: (2025-02-01)

Associated adverse outcomes with tumor treating fields when combined to temozolomide versus temozolomide alone for the treatment of glioblastoma: a meta-analysis of randomized trials
by: Yuanyuan Chen, et al.
Published: (2025-02-01)

Exploration of the optimal deep learning model for english-Japanese machine translation of medical device adverse event terminology
by: Ayako Yagahara, et al.
Published: (2025-02-01)

Prevalence and factors associated with adverse pregnancy outcomes in South Africa: Evidence from the 2016 Demographic and Health Survey
by: L Mpolokeng, et al.
Published: (2024-06-01)

A Collection of Machine Learning Models for Improved Airport Operations Amidst Adverse Weather Conditions
by: Ramon Dalmau, et al.
Published: (2025-02-01)

Urban-rural difference in adverse outcomes of pulmonary tuberculosis in patients with pulmonary tuberculosis-diabetes mellitus comorbidity
by: FANG Zijian, LI Qingchun，XIE Li，SONG Xu，DAI Ruoqi，WU Yifei，JIA Qingjun，CHENG Qinglin
Published: (2025-01-01)

Impact of statin use on major adverse cardiovascular events in patients with normal stress myocardial perfusion imaging and elevated coronary artery calcium score
by: Yi Hui To, et al.
Published: (2023-02-01)

Expanding on Abraxane Safety: Temporal Insights and Future Directions for Adverse Event Analysis [Letter]
by: Yang F, et al.
Published: (2025-02-01)

FREQUENCY OF IRON DEFICIENCY ANEMIA IN PREGNANCY, AND ITSASSOCIATED MATERNAL AND PERINATAL OUTCOMES
by: Naila Qamar, et al.
Published: (2024-07-01)

Adverse Maternal Outcomes and Associated Factors Among Mothers of Advanced Age delivering at a Tertiary Hospital, Southwestern Uganda: A Cross-Sectional Study.
by: Masembe, Sezalio, et al.
Published: (2024)

Prediction of major adverse cardiovascular events following ST-segment elevation myocardial infarction using cardiac obesity marker—epicardial adipose tissue mass index: a prospective cohort study
by: Zeyan Liu, et al.
Published: (2025-02-01)

VUCA environment on project success: The effect of project management methods
by: Ralf Luis de Moura, et al.
Published: (2023-01-01)

Bortezomib, thalidomide, and dexamethasone versus bortezomib, lenalidomide, and dexamethasone in transplant-eligible newly diagnosed multiple myeloma: a systemic review and meta-analysis
by: Yin-Che Wang, et al.
Published: (2025-12-01)

Detection of AdeAB, TetA, and TetB efflux pump genes in clinical isolates of tetracycline-resistant Acinetobacter baumannii from patients of Suez Canal University Hospitals
by: Hasnaa Azab, et al.
Published: (2025-02-01)

Auricular acupressure for minimizing adverse reactions to colonoscopic bowel preparation in hospitalized patients: A randomized controlled trial
by: Jiahui Zhang, et al.
Published: (2025-02-01)

Major adverse cardiovascular events among Black and White Veterans receiving androgen deprivation therapy for prostate cancer: a retrospective cohort study
by: Alexander R. Lucas, et al.
Published: (2025-02-01)